首页 > 市场调查报告书 > 医疗设备

导管

血管移植物市场规模、份额和成长分析（按产品、原料、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902069

血管移植物市场规模、份额和成长分析（按产品、原料、应用、最终用户和地区划分）－2026-2033年产业预测

Vascular Grafts Market Size, Share, and Growth Analysis, By Product (Hemodialysis Access Grafts, Endovascular Stent Grafts), By Raw Material, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球血管移植物市场规模将达到 16 亿美元，到 2025 年将达到 17.2 亿美元，到 2033 年将达到 29.9 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.2%。

心血管疾病发生率的上升预计将成为推动全球血管移植市场成长的主要因素。糖尿病和高血压等疾病的併发症预计也将促进对血管移植的需求成长。此外，全球人口老化为该行业的公司提供了巨大的机会。微创手术日益普及预计将进一步改善血管移植供应商的前景。然而，该市场也面临许多挑战，包括手术併发症的风险、来自其他治疗方法的竞争以及熟练血管外科医生的短缺，这些因素可能会随着时间的推移阻碍行业的成长。总体而言，儘管存在这些潜在障碍，血管移植市场仍呈现扩张的迹象。

全球血管移植市场驱动因素

全球血管移植市场受不健康生活方式和不良习惯导致的心血管疾病发生率上升的推动。动脉粥状硬化、冠状动脉疾病和周边动脉疾病等疾病日益普遍，需要进行血管修復手术和外科介入。随着医疗保健系统积极应对这一不断增长的需求，血管移植的使用量显着增加。心血管健康问题的激增凸显了对有效治疗方法的迫切需求，从而推动了血管移植在医疗保健市场的成长前景。

限制全球血管移植市场发展的因素

全球血管移植市场面临严峻挑战，因为该市场高度依赖技术精湛的外科医生才能成功完成手术。血管移植手术需要专业的知识，这导致全球合格的血管外科医生严重短缺。这种人才短缺会降低整体手术成功率，并导致患者预后不佳。因此，熟练外科医生的数量直接影响血管移植在临床实践中的应用和疗效，并可能阻碍血管移植市场的预期成长。这种人才短缺有可能阻碍这一重要医学领域的发展。

全球血管移植市场趋势

全球血管移植市场正呈现出生物工程血管移植广泛应用的显着趋势。这些移植血管能够高度模拟活体血管的功能，同时最大限度地降低传统血管移植方式相关的感染和免疫排斥风险。生物可吸收材料和再生医学的创新正在推动这项变革，为产业内的新兴企业企业和成熟企业创造了许多机会。这种转变不仅改善了患者的治疗效果，也与日益增长的以患者为中心的先进外科解决方案的需求相吻合，预示着血管移植技术在医疗保健领域正迎来变革性的发展方向。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

WL Gore & Associates, Inc.（US）
Medtronic plc（Ireland）
Cook Medical（US）
Terumo Medical Corporation（Japan）
B. Braun Melsungen AG（Germany）
Getinge AB（Sweden）
CryoLife, Inc.（US）
Cardinal Health（Cordis）（US）
Abbott Laboratories（US）
Endologix Inc.（US）
Vascular Graft Solutions Ltd.（Israel）
Heart Medical Europe BV（Netherlands）
Maquet（Getinge Group）（Germany）
BD（Becton, Dickinson and Company）（US）
Vascudyne, Inc.（US）
VASCULAR GENESIS
BIOVIC Sdn Bhd（Malaysia）

结论与建议

简介目录

Product Code: SQMIG35A2177

Global Vascular Grafts Market size was valued at USD 1.6 Billion in 2024 and is poised to grow from USD 1.72 Billion in 2025 to USD 2.99 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The escalating incidence of cardiovascular diseases is set to be a key driver for growth in the global vascular grafts market. Complications arising from conditions such as diabetes and hypertension are likely to boost demand for vascular grafts. Additionally, the rising elderly population worldwide offers significant opportunities for companies in this sector. The increasing preference for minimally invasive surgical procedures is expected to further enhance prospects for vascular graft providers. However, the market faces challenges, including the risk of complications associated with procedures, competition from alternative treatments, and a shortage of skilled vascular surgeons, which may hinder industry growth over time. Overall, the vascular grafts market is poised for expansion despite these potential obstacles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vascular Grafts Market Segments Analysis

Global Vascular Grafts Market is segmented by Product, Raw Material, Application, End User and region. Based on Product, the market is segmented into Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease and Peripheral Vascular Grafts. Based on Raw Material, the market is segmented into Synthetic Vascular Grafts, Biological Vascular Grafts and Hybrid Vascular Grafts. Based on Application, the market is segmented into Cardiac Aneurysm, Kidney Failure, Vascular Occlusion and Coronary Artery Disease. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vascular Grafts Market

The Global Vascular Grafts market is being propelled by the rising prevalence of cardiovascular diseases linked to poor lifestyle choices and the adoption of unhealthy habits among populations. Conditions like atherosclerosis, coronary artery disease, and peripheral artery disease are becoming increasingly common, necessitating vascular repair procedures and surgical interventions. As healthcare systems respond to this growing demand, the usage of vascular grafts is seeing a notable increase. This surge in cardiovascular health issues highlights the critical need for effective treatment options, thereby enhancing the growth prospects for vascular grafts in the medical market.

Restraints in the Global Vascular Grafts Market

The global vascular grafts market faces significant challenges due to the reliance on highly skilled surgeons for successful procedures. The need for expertise in performing vascular grafting highlights a critical issue: the persistent shortage of qualified vascular surgeons worldwide. This scarcity can impede the overall success rates of these procedures, potentially leading to reduced patient outcomes. As a result, the anticipated growth of the vascular grafts market may be hindered, as the availability of proficient surgical professionals directly impacts both the adoption and effectiveness of vascular grafts in medical practice. This talent gap could stall advancements in this important healthcare segment.

Market Trends of the Global Vascular Grafts Market

The Global Vascular Grafts market is witnessing a significant trend towards the development of bioengineered vascular grafts, which closely replicate the functionality of native blood vessels while minimizing the risks of infection and immune rejection associated with traditional options. Innovations in bioresorbable materials and regenerative medicine are driving this evolution, paving the way for an array of opportunities for both emerging and established players within the industry. This shift not only enhances patient outcomes but also aligns with the growing demand for advanced, patient-centered surgical solutions, suggesting a transformative direction for vascular graft technologies in the healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Vascular Grafts Market Size by Product & CAGR (2026-2033)

Market Overview
Hemodialysis Access Grafts
Endovascular Stent Grafts
- Abdominal Aortic Aneurysms Repair
- Thoracic Aortic Aneurysm Repair
Coronary Artery By-Pass Grafts
Vascular Grafts for Aorta Disease
Peripheral Vascular Grafts

Global Vascular Grafts Market Size by Raw Material & CAGR (2026-2033)

Market Overview
Synthetic Vascular Grafts
- Polytetrafluoroethylene (PTFE) Grafts
- Polyester Grafts
- Polyurethane Grafts
Biological Vascular Grafts
- Autografts
- Allografts
- Xenografts
Hybrid Vascular Grafts

Global Vascular Grafts Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiac Aneurysm
- Endovascular Stent Graft
- Vascular Graft
Kidney Failure
Vascular Occlusion
Coronary Artery Disease

Global Vascular Grafts Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers

Global Vascular Grafts Market Size & CAGR (2026-2033)

North America (Product, Raw Material, Application, End User)
- US
- Canada
Europe (Product, Raw Material, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Raw Material, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Raw Material, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Raw Material, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

W. L. Gore & Associates, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Medical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (Cordis) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Graft Solutions Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heart Medical Europe BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maquet (Getinge Group) (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascudyne, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VASCULAR GENESIS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOVIC Sdn Bhd (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments